(2839) Cost Burden of Patients with Oral Antibiotic Treatment Failure for Uncomplicated Urinary Tract Infection in the United States

Saturday, October 14, 2023

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Co-Author(s)

MF

Meg Franklin, PharmaD, PhD

PRECISIONheor, Boston, MA, USA; Franklin Pharmaceutical Consulting, Cary, NC, USA
Boston, Massachusetts, United States
ME

Maia R. Emden, BA

PRECISIONheor
Boston, Massachusetts, United States
SK

Sharon Kautz, BS

PRECISIONheor, Boston, MA, USA
Boston, Massachusetts, United States
AN

Anh Thy H. Nguyen, MSPH

PRECISIONheor, Boston, MA, USA
Boston, Massachusetts, United States
NS

Naomi C. Sacks, PhD

PRECISIONheor, Boston, MA, USA
Boston, Massachusetts, United States
SJ

Shinyoung Ju, MS

GSK
Brentford, England, United Kingdom
FM

Fanny S. Mitrani-Gold, MPH

Director, Epidemiology
GlaxoSmithKline plc.
Collegeville, Pennsylvania, United States
Ashish V. Joshi, PhD

Senior Director
GlaxoSmithKline plc.
Collegeville, Pennsylvania, United States